Ventyx Biosciences Inc.
1.99
0.05 (2.58%)
At close: Jan 15, 2025, 2:34 PM

Ventyx Biosciences Statistics

Share Statistics

Ventyx Biosciences has 70.71M shares outstanding. The number of shares has increased by 19.34% in one year.

Shares Outstanding 70.71M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.06%
Owned by Institutions (%) n/a
Shares Floating 52.89M
Failed to Deliver (FTD) Shares 290
FTD / Avg. Volume 0.02%

Short Selling Information

The latest short interest is 8.63M, so 12.21% of the outstanding shares have been sold short.

Short Interest 8.63M
Short % of Shares Out 12.21%
Short % of Float 16.29%
Short Ratio (days to cover) 4.15

Valuation Ratios

The PE ratio is -0.75 and the forward PE ratio is -0.99.

PE Ratio -0.75
Forward PE -0.99
PS Ratio 0
Forward PS 8.9
PB Ratio 0.59
P/FCF Ratio -0.87
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ventyx Biosciences Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.87, with a Debt / Equity ratio of 0.05.

Current Ratio 11.87
Quick Ratio 11.87
Debt / Equity 0.05
Total Debt / Capitalization 4.88
Cash Flow / Debt -13.32
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.79% and return on capital (ROIC) is -81.11%.

Return on Equity (ROE) -0.79%
Return on Assets (ROA) -0.69%
Return on Capital (ROIC) -81.11%
Revenue Per Employee 0
Profits Per Employee -2.57M
Employee Count 75
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -9.81% in the last 52 weeks. The beta is 0.37, so Ventyx Biosciences 's price volatility has been higher than the market average.

Beta 0.37
52-Week Price Change -9.81%
50-Day Moving Average 2.27
200-Day Moving Average 2.89
Relative Strength Index (RSI) 39.33
Average Volume (20 Days) 1.64M

Income Statement

Revenue n/a
Gross Profit -941.00K
Operating Income -207.99M
Net Income -192.96M
EBITDA -207.84M
EBIT n/a
Earnings Per Share (EPS) -3.3
Full Income Statement

Balance Sheet

The company has 51.58M in cash and 12.51M in debt, giving a net cash position of 39.07M.

Cash & Cash Equivalents 51.58M
Total Debt 12.51M
Net Cash 39.07M
Retained Earnings -419.19M
Total Assets 301.10M
Working Capital 277.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -166.52M and capital expenditures -514.00K, giving a free cash flow of -167.04M.

Operating Cash Flow -166.52M
Capital Expenditures -514.00K
Free Cash Flow -167.04M
FCF Per Share -2.85
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

VTYX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -170.98%
FCF Yield -122.4%
Dividend Details

Analyst Forecast

The average price target for VTYX is $11, which is 469.9% higher than the current price. The consensus rating is "Buy".

Price Target $11
Price Target Difference 469.9%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Scores

Altman Z-Score 1.57
Piotroski F-Score 2